Skip to main content
Equibles
CLB logo

CLB · Core Laboratories Inc. /DE/

Track CLB — free

Use CLB with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CLB

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$12.45 +0.06 (+0.48%) At close · Aug 14
Market Cap
$571.26M
Shares
45.88M

Core Laboratories Inc. Earnings Call Transcripts

Every quarterly earnings call for Core Laboratories Inc. (CLB) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $125.97M $7.52M '22 Q3 22-09-30 · $128.36M $2.37M '23 Q1 23-03-31 ▲5.8% $127.88M $22.85M '23 Q2 23-07-26 ▼0.5% $125.34M $9.26M '23 Q3 23-11-01 · $128.21M $2.20M '23 Q4 24-01-31 ▲1% $129.64M $3.22M '24 Q1 24-04-24 ▲2.1% $130.58M $9.03M '24 Q2 24-07-24 ▲7.2% $134.40M $11.74M '24 Q3 24-10-23 ▲0.8% $129.24M $7.40M '24 Q4 25-01-29 ▼4.7% $123.58M −$154,000 '25 Q1 25-04-23 ▼0.3% $130.16M $10.64M '25 Q2 25-07-23 ▲0.1% $134.52M $14.24M '25 Q3 25-10-22 ▲7% $138.25M $4.95M '25 Q4 26-02-05 ▼1.4% $121.80M −$789,000 '26 Q1 26-04-30 LATEST ▼4.3% $124.61M $5.96M '26 Q2 26-07-30
Earnings call
FY26 · Q2
2026-07-30
Core Laboratories Inc. /DE/ Q2 FY2026 Earnings Call
Revenue
$124.61M
▼ 4.3% YoY
Diluted EPS
$0.13
▼ 40.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-30
Core Laboratories Inc. /DE/ Q1 FY2026 Earnings Call
Cautious tone Reservoir Description segment Production Enhancement segment Shareholder returns and capital allocation
Revenue
$121.80M
▼ 1.4% YoY
Diluted EPS
$-0.02
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-05
Core Laboratories Inc. /DE/ Q4 FY2025 Earnings Call
Positive tone International demand and Reservoir Description growth Production Enhancement performance and APAC receivable Capital returns and shareholder value
Revenue
$138.25M*
▲ 7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-22
Core Laboratories Inc. /DE/ Q3 FY2025 Earnings Call
Positive tone Sequential revenue and margin improvement Capital return and shareholder value Reservoir Description segment performance
Revenue
$134.52M
▲ 0.1% YoY
Diluted EPS
$0.30
▲ 20% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-23
Core Laboratories Inc. /DE/ Q2 FY2025 Earnings Call
Positive tone Sequential revenue and margin improvement Production Enhancement segment Reservoir Description segment
Revenue
$130.16M
▼ 0.3% YoY
Diluted EPS
$0.22
▲ 15.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-23
Core Laboratories Inc. /DE/ Q1 FY2025 Earnings Call
Balanced tone Geopolitical conflicts and sanctions impact Production Enhancement segment International growth opportunities
Revenue
$123.58M
▼ 4.7% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-01-29
Core Laboratories Inc. /DE/ Q4 FY2024 Earnings Call
Positive tone Reservoir Description segment performance Technology and innovation strategy Balance sheet and deleveraging
Revenue
$129.24M*
▲ 0.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-23
Core Laboratories Inc. /DE/ Q3 FY2024 Earnings Call
Balanced tone Revenue growth and sequential improvement Free cash flow and shareholder returns Reservoir Description and international services
Revenue
$134.40M
▲ 7.2% YoY
Diluted EPS
$0.25
▲ 31.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-24
Core Laboratories Inc. /DE/ Q2 FY2024 Earnings Call
Positive tone Debt Reduction and Balance Sheet Sequential Financial Improvement Production Enhancement Segment
Revenue
$130.58M
▲ 2.1% YoY
Diluted EPS
$0.19
▼ 60.4% YoY
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-24
Core Laboratories Inc. /DE/ Q1 FY2024 Earnings Call
Positive tone Sequential revenue and margins Geopolitical disruption to crude oil flows Production Enhancement segment
Revenue
$129.64M
▲ 1% YoY
Diluted EPS
$0.07
▲ 40% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-01-31
Core Laboratories Inc. /DE/ Q4 FY2023 Earnings Call
Positive tone Operational momentum and reservoir description demand International and Middle East project activity Production Enhancement segment
Revenue
$128.21M*
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Core Laboratories Inc. /DE/ Q3 FY2023 Earnings Call
Revenue
$125.34M
▼ 0.5% YoY
Diluted EPS
$0.19
▲ 18.8% YoY
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-26
Core Laboratories Inc. /DE/ Q2 FY2023 Earnings Call
Revenue
$127.88M
▲ 5.8% YoY
Diluted EPS
$0.48
▲ 220% YoY
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Core Laboratories Inc. /DE/ Q1 FY2023 Earnings Call
Revenue
$128.36M
Diluted EPS
$0.05
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Core Laboratories Inc. /DE/ Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Core Laboratories Inc. /DE/ Q3 FY2022 Earnings Call
Revenue
$125.97M
Diluted EPS
$0.16
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Core Laboratories Inc. /DE/ Q2 FY2022 Earnings Call
Revenue
$120.90M
Diluted EPS
$0.15
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Core Laboratories Inc. /DE/ Q1 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Core Laboratories Inc. /DE/ Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Core Laboratories Inc. /DE/ Q3 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Core Laboratories Inc. /DE/ Q2 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Core Laboratories Inc. /DE/ Q1 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Core Laboratories Inc. /DE/ Q4 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
Core Laboratories Inc. /DE/ Q3 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Core Laboratories Inc. /DE/ Q2 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Core Laboratories Inc. /DE/ Q1 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–26 of 26 earnings calls
Key facts CIK 1958086 CUSIP 21867A105 13F (30d) 181 filings 177 filers Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)